Evidências sobre a eficácia e limitações dos antidepressivos ISRS no tratamento da depressão maior

Major depressive disorder is an important public health problem, affecting functioning and quality of life. This study aims to evaluate the efficacy and limitations of selective serotonin reuptake inhibitors (SSRIs) in adults with major depression. It is a qualitative, descriptive literature review based on national and international publications addressing clinical response, tolerability, adherence, and treatment continuity. Evidence discussed in the theoretical background indicates benefits of antidepressants compared with placebo, although individual differences in response and limitations related to adverse events, early discontinuation, and access to care remain. Fluoxetine, used in the Brazilian public health system, and escitalopram are relevant drugs for within-class comparisons. The preliminary conclusion is that SSRIs remain important therapeutic options, but their use requires individualized assessment of efficacy, safety, and adherence. The structured selection of studies must be completed before definitive review results can be reported.

Authors

Publication Details

Journal
Revista fisio&terapia.
Published
2026-11-15
DOI
https://doi.org/10.69849/gb9jny19
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evidências sobre a eficácia e limitações dos antidepressivos ISRS no tratamento da depressão maior

Carlos Alberto de Paula Dias Neto, Anna Clara Barbosa Gomes, Adriano de Sá Peixoto Teles
Revista fisio&terapia.
Treatment of Major Depression
article

Evidências sobre a eficácia e limitações dos antidepressivos ISRS no tratamento da depressão maior

Carlos Alberto de Paula Dias Neto, Anna Clara Barbosa Gomes, Adriano de Sá Peixoto Teles
article en

Abstract

Major depressive disorder is an important public health problem, affecting functioning and quality of life. This study aims to evaluate the efficacy and limitations of selective serotonin reuptake inhibitors (SSRIs) in adults with major depression. It is a qualitative, descriptive literature review based on national and international publications addressing clinical response, tolerability, adherence, and treatment continuity. Evidence discussed in the theoretical background indicates benefits of antidepressants compared with placebo, although individual differences in response and limitations related to adverse events, early discontinuation, and access to care remain. Fluoxetine, used in the Brazilian public health system, and escitalopram are relevant drugs for within-class comparisons. The preliminary conclusion is that SSRIs remain important therapeutic options, but their use requires individualized assessment of efficacy, safety, and adherence. The structured selection of studies must be completed before definitive review results can be reported.

Revista fisio&terapia.Vol. 30(164)
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon